EMEA-001973-PIP01-16
Key facts
| Active substance |
Teprotumumab
|
| Decision number |
P/0345/2016
|
| PIP number |
EMEA-001973-PIP01-16
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of active thyroid eye disease
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
River Vision Development Corporation
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|